Home Tools
Log in
Cart

SB-505124

Catalog No. T2462   CAS 694433-59-5

SB505124 is a selective inhibitor of TGFβR for ALK4, ALK5.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
SB-505124 Chemical Structure
SB-505124, CAS 694433-59-5
Pack Size Availability Price/USD Quantity
1 mg In stock $ 34.00
2 mg In stock $ 48.00
5 mg In stock $ 81.00
10 mg In stock $ 129.00
25 mg In stock $ 233.00
50 mg In stock $ 393.00
100 mg In stock $ 576.00
500 mg In stock $ 1,220.00
1 mL * 10 mM (in DMSO) In stock $ 142.00
Bulk Inquiry
Get quote
Select Batch  
Purity: 99.92%
Purity: 99%
Purity: 98.74%
Purity: 97.88%
Contact us for more batch information
Biological Description
Chemical Properties
Storage & Solubility Information
Description SB505124 is a selective inhibitor of TGFβR for ALK4, ALK5.
Targets&IC50 ALK5:47 nM, ALK4:129 nM
In vitro In the rabbit GFS model, SB505124 reduced intraocular pressure (IOP) at the GFS surgical site and diminished subconjunctival cellular infiltration and scarring. Additionally, in mice treated with tacrolimus (TAC) and FK12EC KO mice, SB505124 inhibited the activation of endothelial TGF-β receptors and the induction of hyalinosis in renal arterioles.
In vivo SB505124 has been identified as a reversible ATP-competitive and selective inhibitor of ALK4 and ALK5. It inhibits ALK4 with an IC50 of 129 nM, exhibiting 2.5 times less selectivity towards ALK5, and does not inhibit ALK2 at concentrations up to 10 μM. SB505124 suppresses endogenous Smad2 phosphorylation in COS-1 cells. Both ALK4 and ALK5 activation lead to Smad1 and Smad2 phosphorylation, with SB505124 inhibiting this activation. This compound, in a concentration-dependent manner, inhibits Transforming Growth Factor-β (TGF-β)-induced Smad2 phosphorylation in HepG2 human liver cancer cells, C2C12 mouse myoblasts, and Mv1Lu mink lung cells. SB505124 effectively inhibits the activity of TGF-β and activin-induced CAGA12-luciferase and ARE-luciferase reporter constructs in a concentration-dependent fashion. In Human Umbilical Vein Endothelial Cells (HUVEC), SB505124 (500 nM) obstructs the effects of TGF-β1 on F-actin assembly and prevents TGF-β-induced ROS production.
Kinase Assay In Vitro Protein Kinase Assay : Kinase assays are performed as described by Laping et al., 2002 using the kinase domain of ALK5 and full-length N-terminal fused GST-Smad3. Kinase assays are performed with 65 nM GST-ALK5 and 184 nM GST-Smad3 in 50 mM HEPES, 5 mM MgCl2, 1 mM CaCl2, 1 mM dithiothreitol, and 3 μM ATP. Reactions are incubated with 0.5 μCi of [33P]γATP for 3 hours at 30 °C. Phosphorylated protein is captured on P-81 paper , washed with 0.5% phosphoric acid, and counted by liquid scintillation. Alternatively, Smad3 or Smad1 protein is also coated onto FlashPlate Sterile Basic Microplates. Kinase assays are then performed in FlashPlates with same assay conditions using either the kinase domain of ALK5 with Smad3 as substrate or the kinase domain of ALK6 (BMP receptor) with Smad1 as substrate. Plates are washed three times with phosphate buffer and counted by TopCount.
Cell Research Cell viability is measured as described by Laping et al., 2002 or by using the modified tetrazolium salt WST-1. XTT assay: The cells are serum-deprived for 24 hours and then treated with SB505124 for 48 hours to assess the cellular toxicity. Cell viability is determined by incubating cells for 4 hours with XTT labeling and electron coupling reagent according to the manufacturer's directions. Live cells with active mitochondria produce an orange-colored product, formazan, which is detected using a plate reader at between A450 nm and A500 nm with a reference wavelength greater than 600 nm. The absorbance values correlate with the number of viable cells. Modified tetrazolium salt WST-1: Approximately 2000 cells are seeded in 96-well dishes in 100 μL of 0.2% FBS phenol red-free media overnight. The cells are treated with 50 μL of SB505124 (to achieve the final concentrations indicated) for 30 minutes before being treated with or without TGF-β1 and TNF-α to a final volume of 200 μL. Cell growth is measured at the indicated time points by incubating each well with 10 μL of WST-1 for 3 hours at 37 °C. Metabolically active cells cleave WST-1 to water-soluble formazan, which is directly quantitated with an enzyme-linked immunosorbent assay plate reader. Each experiment is done at least twice, and treatment for each cell line is done in triplicate.(Only for Reference)
Molecular Weight 335.4
Formula C20H21N3O2
CAS No. 694433-59-5

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Solubility Information

DMSO: 33.5 mg/mL (100 mM)

1eq. HCl: 33.5 mg/mL (100 mM)

TargetMolReferences and Literature

1. DaCosta Byfield S, et al. Mol Pharmacol. 2004, 65(3), 744-752. 2. Hu T, et al. Am J Physiol Renal Physiol. 2005, 289(4), F816-825. 3. Misumi S, et al. Eur J Neurosci. 2008, 28(6), 1049-1059. 4. Goto N, et al. Cancer Sci. 2011, 102(8), 1501-1508. 5. Sapitro J, et al. Mol Vis. 2010 ,16, 1880-1892. 6. Marini KD, et al. Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy. Sci Transl Med. 2018 Jul 25;10(451). pii: eaat3504. 7. Kalli M, Mpekris F, Wong C K, et al. Activin A signaling regulates IL13Rα2 expression to promote breast cancer metastasis[J]. Frontiers in oncology. 2019 Feb 5;9:32.

TargetMolCitations

1. Kalli M, Mpekris F, Wong C K, et al. Activin A signaling regulates IL13Rα2 expression to promote breast cancer metastasis. Frontiers in Oncology. 2019 Feb 5;9:32 2. Liu S, Yu X, Guo Q, et al.Periodontal ligament‐associated protein‐1 promotes osteoclastogenesis in mice by modulating TGF‐β1/Smad1 pathway.Journal of Periodontology.2023

Related compound libraries

This product is contained In the following compound libraries:
Kinase Inhibitor Library Inhibitor Library TGF-beta/Smad Compound Library Tyrosine Kinase Inhibitor Library Anti-Cancer Active Compound Library Stem Cell Differentiation Compound Library Anti-Obesity Compound Library Bioactive Compound Library Anti-Ovarian Cancer Compound Library Anti-Cancer Compound Library

Related Products

Related compounds with same targets
X-376 Repotrectinib Vactosertib Hydrochloride A 83-01 sodium salt CH5424802 analog ALK inhibitor 2 MS4077 N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-bromoaniline

TargetMolDose Conversion

You can also refer to dose conversion for different animals. More

TargetMol In vivo Formulation Calculator (Clear solution)

Step One: Enter information below
Dosage
mg/kg
Average weight of animals
g
Dosing volume per animal
ul
Number of animals
Step Two: Enter the in vivo formulation
% DMSO
%
% Tween 80
% ddH2O
Calculate Reset

TargetMolCalculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculation
Molecular Weight Calculator
=
X
X

Molarity Calculator allows you to calculate the

  • Mass of a compound required to prepare a solution of known volume and concentration
  • Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Concentration of a solution resulting from a known mass of compound in a specific volume
See Example

An example of a molarity calculation using the molarity calculator
What is the mass of compound required to make a 10 mM stock solution in 10 ml of water given that the molecular weight of the compound is 197.13 g/mol?
Enter 197.13 into the Molecular Weight (MW) box
Enter 10 into the Concentration box and select the correct unit (millimolar)
Enter 10 into the Volume box and select the correct unit (milliliter)
Press calculate
The answer of 19.713 mg appears in the Mass box

X
=
X

Calculator the dilution required to prepare a stock solution

Calculate the dilution required to prepare a stock solution
The dilution calculator is a useful tool which allows you to calculate how to dilute a stock solution of known concentration. Enter C1, C2 & V2 to calculate V1.

See Example

An example of a dilution calculation using the Tocris dilution calculator
What volume of a given 10 mM stock solution is required to make 20ml of a 50 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=50 μM, V2=20 ml and V1 is the unknown:
Enter 10 into the Concentration (start) box and select the correct unit (millimolar)
Enter 50 into the Concentration (final) box and select the correct unit (micromolar)
Enter 20 into the Volume (final) box and select the correct unit (milliliter)
Press calculate
The answer of 100 microliter (0.1 ml) appears in the Volume (start) box

=
/

Calculate the volume of solvent required to reconstitute your vial.

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial.
Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

g/mol

Enter the chemical formula of a compound to calculate its molar mass and elemental composition

Tip: Chemical formula is case sensitive: C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed n the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

bottom

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.

Keywords

SB-505124 694433-59-5 Angiogenesis Stem Cells Tyrosine Kinase/Adaptors TGF-beta/Smad ALK SB505124 SB 505124 Transforming growth factor beta receptors TGF-β Receptor Inhibitor inhibit inhibitor

 

TargetMol